Next Article in Journal
Vitamin D Status, Calcium Intake and Risk of Developing Type 2 Diabetes: An Unresolved Issue
Previous Article in Journal
Supplementation with Hydroxytyrosol and Punicalagin Improves Early Atherosclerosis Markers Involved in the Asymptomatic Phase of Atherosclerosis in the Adult Population: A Randomized, Placebo-Controlled, Crossover Trial
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Cyanidin Increases the Expression of Mg2+ Transport Carriers Mediated by the Activation of PPARα in Colonic Epithelial MCE301 Cells

1
Laboratory of Biochemistry, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical University, Gifu 501-1196, Japan
2
Life Science Research Center, University of Toyama, Toyama 930-0194, Japan
*
Author to whom correspondence should be addressed.
Nutrients 2019, 11(3), 641; https://doi.org/10.3390/nu11030641
Submission received: 14 February 2019 / Revised: 13 March 2019 / Accepted: 13 March 2019 / Published: 16 March 2019

Abstract

:
Mg2+ deficiency may be involved in lifestyle-related diseases, including hypertension, cardiovascular diseases, and diabetes mellitus. Dietary Mg2+ is absorbed in the intestine mediated through transcellular and paracellular pathways. However, there is little research into what factors upregulate Mg2+ absorption. We searched for food constituents that can increase the expression levels of Mg2+ transport carriers using mouse colonic epithelial MCE301 cells. Cyanidin, an anthocyanidin found in black beans and berries, increased the mRNA levels of Mg2+ transport carriers including transient receptor potential melastatin 6 (TRPM6) channel and cyclin M4 (CNNM4). The cyanidin-induced elevation of Mg2+ transport carriers was blocked by GW6471, a peroxisome proliferator-activated receptor α (PPARα) inhibitor, but not by PPARγ, PPARδ, and protein kinase A inhibitors. Cyanidin-3-glucoside showed similar results to cyanidin. Cyanidin increased the protein levels of TRPM6 and CNNM4, which were distributed in the apical and lateral membranes, respectively. The nuclear localization of PPARα and reporter activities of Mg2+ transport carriers were increased by cyanidin, which were inhibited by GW6471. The cyanidin-induced elevation of reporter activity was suppressed by a mutation in a PPAR-response element. Fluorescence measurements using KMG-20, an Mg2+ indicator, showed that Mg2+ influx and efflux from the cells were enhanced by cyanidin, and which were inhibited by GW6471. Furthermore, cyanidin increased paracellular Mg2+ flux without affecting transepithelial electrical resistance. We suggest that cyanidin increases intestinal Mg2+ absorption mediated by the elevation of TRPM6 and CNNM4 expression, and may constitute a phytochemical that can improve Mg2+ deficiency.

Graphical Abstract

1. Introduction

Magnesium ions (Mg2+) play an important role in the regulation of various physiological functions. Over 300 enzymes, including those involved with oxidative phosphorylation and glycolysis, require Mg2+ for their activity. Chronic Mg2+ deficiency may be one of the causes of lifestyle-related diseases such as hypertension, cardiovascular diseases, and diabetes mellitus [1,2,3]. In addition, Mg2+ is necessary to protect individuals from physical and mental stresses [4,5]. Mg2+ deficiency due to reduced dietary intake in healthy people may be rare. However, many people are exposed to excessive stress in their social environment, and such stress is thought to be increasing and limiting to health complications. Mg2+ has the capability to relieve tension stress. Therefore, Mg2+ consumption and excretion are growing at an impressive rate. Moreover, high fat and energy diets may lead to defects in Mg2+ intake. Individuals under excessive stress and with an unbalanced diet may have a higher risk of chronic Mg2+ deficiency. Excess intake of Mg2+ may cause diarrhea, resulting in the further deterioration of Mg2+ deficiency. Therefore, it may be more effective to take a food constituent that enhances Mg2+ absorption.
The daily intake of Mg2+ for a normal adult is about 300–400 mg and approximately 30%–50% is absorbed in the intestine. The intestinal absorption rate of Mg2+ depends on the amount of Mg2+ intake [6] and is enhanced when Mg2+ intake is low [7]. The absorption of Mg2+ occurs mostly in the small intestine and colon, and the absorption routes are divided into two pathways, transcellular, and paracellular. The absorption of Mg2+ in the colon mainly depends on the transcellular pathway [8]. The transient receptor potential melastatin 6 (TRPM6) Mg2+ channel is exclusively expressed at the apical membrane of the colon and renal distal convoluted tubules [9]. The TRPM6 gene has been identified as the causative gene of a rare autosomal recessive disorder, hypomagnesemia with secondary hypocalcemia [10,11]. On the other hand, TRPM7, a close homologue of TRPM6, is expressed ubiquitously in a broad spectrum of tissues. Cyclin M4 (CNNM4, previously known as ancient domain protein 4) is expressed at the basolateral membrane of the intestine and is considered to function as an Mg2+ transporter [12]. A correlation between reduced serum Mg2+ concentration and single nucleotide polymorphisms in CNNM genes, including CNNM4, has been shown by genome-wide association studies [13]. Both TRPM6 and CNNM4 may be responsible for the absorption of Mg2+ in the colon. However, the regulatory mechanism of expression of these Mg2+ transport carriers remains unclear.
Mg2+ absorption is impaired by some food components such as phytic acid and oxalate [14]. In contrast, magnesiotropic hormones including parathyroid hormone, 1,25 dihydroxyvitamin D, and epidermal growth factor (EGF) have been suggested to up-regulate Mg2+ absorption [15], but there are few reports about food components. Mg2+ is abundant in nuts, vegetables, and fruits [16]. Black soybean, which contains various bioactive components, including flavonols, anthocyanins, polyphenols, and linoleic acid, have been reported to be useful in supplying Mg2+ in serum [17]. Cyanidin-3-O-glucoside (cyanidin-3G), one of the most common anthocyanins, is absorbed in the intestine and may produce cyanidin through hydrolysis by β-glucosidase [18]. Both cyanidin and cyanidin-3G have various bioactivities, such as anti-tumor, anti-infection, and anti-diabetic properties [19], but there are no reports concerning mineral absorption in the colon.
In the present study, we found that cyanidin increases the mRNA and protein levels of TRPM6 and CNNM4 in mouse colonic epithelial MCE301 cells. Consequently, the effects of cyanidin on intracellular localization, transcriptional activity, and Mg2+ flux through TRPM6 and CNNM4 were investigated using immunofluorescence measurements, luciferase assay, and Mg2+ fluorescence measurements, respectively. In addition, the binding of peroxisome proliferator-activated receptor α (PPARα) to the promoter region of these Mg2+ transport carriers was determined using chromatin immunoprecipitation (ChIP) assays. Our findings indicate that cyanidin may be useful to increase Mg2+ absorption in the intestine and prevent chronic Mg2+ deficiency.

2. Experimental Section

2.1. Materials

Genistein, GW9662, and linoleic acid were purchased from Wako Pure Chemical Industries (Osaka, Japan). GSK3787, GW6471, and H-89 were from Cayman Chemical (Ann Arbor, MI, USA). Cyanidin and cyanidin-3G were from TOKIWA PHYTOCHEMICAL (Chiba, Tokyo) and FUJICCO (Kobe, Japan), respectively. Anti-CNNM4, anti-PPARα, anti-TRPM6 (CHAK2), and anti-TRPM7 antibodies were from GeneTex (Hsinchu, Taiwan), Rockland (Limerick, PA, USA), Abgent (San Diego, CA, USA), and Imgenex (San Diego, CA, USA), respectively. All other reagents were of the highest grade of purity available. The pharmacological effects of drugs are listed in Table 1.

2.2. Cell Culture

Mouse colonic non-carcinoma epithelial MCE301 cells derived from transgenic mice [20] were grown in Dulbecco’s modified Eagle’s medium/Ham’s nutrient mixture F-12, as described previously [21]. The cells were cultured in the medium without fetal bovine serum the day before the experiments. Control cells were treated with dimethyl sulfoxide (DMSO) as a vehicle.

2.3. RNA Isolation and Quantitative Real-Time Reverse-Transcription Polymerase Chain Reaction (PCR)

Total RNA was isolated from cells using TRI reagent (Sigma-Aldrich, St. Louis, MO, USA). Reverse transcription and quantitative real-time PCR was performed, as described previously [21]. The primer pairs used for PCR are listed in Table 2. β-Actin was used for normalization.

2.4. Preparation of Cytoplasmic Extracts and Western Blotting

Cytoplasmic extracts, which include plasma membrane and cytosolic proteins, were prepared, as described previously [22]. The aliquots were applied to sodium dodecyl sulfate-polyacrylamide gel electrophoresis and blotted onto a polyvinylidene fluoride membrane. After blocking with 2% skim milk at room temperature for 30 min, the membrane was incubated with each primary antibody (1:1000 dilution) at 4 °C for 16 h, followed by a peroxidase-conjugated secondary antibody (1:3000 dilution) at room temperature for 1.5 h. Finally, the membranes were incubated in EzWestLumi plus (ATTO Corporation, Tokyo, Japan) and scanned using a C-DiGit Blot Scanner (LI-COR Biotechnology, Lincoln, NE, USA). Band density was quantified using ImageJ software (National Institute of Health software). β-Actin was used for normalization of cytoplasmic proteins.

2.5. Immunocytochemistry

Cells cultured on Transwell plates (0.4 μm pore size, Corning Incorporated, Corning, NY, USA) were fixed with 3.7% paraformaldehyde at room temperature, then permeabilized with 0.2% Triton X-100 for 15 min. After blocking with 4% Block Ace (Dainippon Sumitomo Pharma, Osaka, Japan) for 30 min, the cells were incubated with primary antibodies at 4 °C for 16 h. They were then incubated with Alexa Fluor 488 and 546-conjugated antibodies in the presence of 4′,6-diamidino-2-phenylindole (DAPI) for 1.5 h at room temperature. Immunolabelled cells were visualized using an LSM700 confocal microscope (Carl Zeiss, Germany). The fluorescence intensity of PPARα was quantified using ImageJ software and the nuclear localization was shown as a percentage of total intensity.

2.6. Luciferase Reporter Assay

pGL4 luciferase reporter vectors (Promega, Madison, WI, USA) containing the promoter region of the TRPM6 (NM_017662.4) or CNNM4 (NM_033570.2) were constructed. A Renilla construct, pRL-TK vector (Promega), was used for normalizing transfection efficiency. Cells were transfected with plasmid vector using HilyMax (Dojindo Laboratories, Kumamoto, Japan). After 48 h of transfection, luciferase activity was assessed using the Dual-Glo Luciferase Assay System (Promega). The luminescence of the firefly and renilla luciferase was measured using an AB-2270 Luminescencer Octa (Atto Corporation, Tokyo, Japan). Using computer analysis (TRANSFAC databases, Match), putative PPAR response elements (PPREs) were identified in the promoter region between −1214 and −718 of the TRPM6 gene and between −341 and −323 of the CNNM4 gene. Mutants of PPREs were generated using a KOD mutagenesis kit (Toyobo Life Science, Osaka, Japan). The primer pairs used for the introduction of mutation are listed in Table 3.

2.7. ChIP Assay

Cells were treated with 1% formaldehyde to crosslink the protein to DNA. Then, ChIP assays were performed using an EpiQuik Chromatin Immunoprecipitation kit (Epigentek, Farmingdale, NY, USA) as recommended by the manufacturer’s instructions. To co-immunoprecipitate the DNA, anti-PPARα antibody was used. The eluted DNA was amplified by semi-quantitative and quantitative real-time PCR using the primer pairs as shown in Table 4. To confirm usage of the same amounts of chromatin in immunoprecipitation between groups, input chromatin was also used. ChIP data are represented as relative values in the cells treated with cyanidin alone.

2.8. Mg2+ Transport Assay

The change in intracellular free Mg2+ concentration ([Mg2+]i) was determined using a Mg2+-sensitive fluorescent dye, KMG-20 AM. Cells cultured on 96-well plates were loaded with Hanks balanced salt solution (HBSS) containing 137 mM NaCl, 5.4 mM KCl, 4.2 mM NaHCO3, 3 mM Na2HPO4, 0.4 mM KH2PO4, 5 mM HEPES, 1 mM CaCl2, and 10 mM glucose supplemented with 2 μM KMG-20 at 37 °C for 30 min. The KMG-20-loaded cells were washed twice with dye-free HBSS and the fluorescence was measured every 20 s at 535 nm after excitation at 430 and 485 nm using a fluorescence reader (Infinite F200 Pro, Tecan, Mannedorf, Switzerland). In the Mg2+ influx assay, MgCl2 (final concentration 1 mM) was added to the nominally Mg2+-free HBSS immediately after measurement start. [Mg2+]i is represented as arbitrary units relative to a reference value measured at 0 min. The increases in fluorescence values for 5 min after measurement start (ΔA.U.) were compared in each group. In the Mg2+ efflux assay, the HBSS supplemented with 1 mM MgCl2 was replaced at the nominally Mg2+-free HBSS immediately after measurement started. The decreases in fluorescence values for 5 min after measurement start (ΔA.U.) were compared in each group. In the transepithelial Mg2+ flux assay, cells were cultured on Transwell plates. After forming the confluent monolayer, transepithelial electrical resistance (TER) was measured, as described previously [23]. The upper and lower chamber media were replaced to the nominally Mg2+-free HBSS. After 60 min of 1 mM MgCl2 addition to the upper chamber, the lower chamber solution was collected. The concentration of Mg2+ was measured by a colorimetric method using xylidyl blue-I (XB-I). XB-I formed a 520 nm absorbance maximum complex upon Mg2+ binding in alkaline conditions. After calibration, the concentration of Mg2+ was calculated.

2.9. Statistics

Results are presented as mean ± standard error of the mean. Differences between groups were analyzed using a one-way analysis of variance, and corrections for multiple comparison were made using Tukey’s multiple comparison tests. Comparisons between two groups were made using Student’s t test. Significant differences were assumed at p < 0.05.

3. Results

3.1. Increase in TRPM6 and CNNM4 mRNA Expression by Cyanidin

To identify food constituents that can increase intestinal Mg2+ absorption, we examined the effect of black bean components including genistein, cyanidin, and linoleic acid on the mRNA levels of Mg2+ transport carriers. Cyanidin significantly increased the mRNA levels of TRPM6 and CNNM4 without affecting that of TRPM7 (Figure 1). Similarly, cyanidin-3G increased the mRNA levels of TRPM6 and CNNM4 (Figure 2). Anthocyanin has been reported to activate protein kinase A (PKA) [24] and PPAR [25]. The cyanidin and cyanidin-3G-induced elevation of TRPM6 and CNNM4 mRNAs was significantly blocked by GW6471, a PPARα inhibitor. In contrast, GW9662, a PPARγ inhibitor, GSK3787, a PPARδ inhibitor, and H-89, a PKA inhibitor had no effect on the cyanidin-induced elevation of TRPM6 and CNNM4 mRNAs. These results indicate that cyanidin may increase the expression of both TRPM6 and CNNM4 mediated by the activation of PPARα.

3.2. Effect of Cyanidin on the Expression and Localization of TRPM6 and CNNM4 Proteins

TRPM6 may be localized in the apical membrane and play a role in the Mg2+ influx from the intestinal lumen to cells, whereas CNNM4 may be localized in the basolateral membrane and play a role in Mg2+ efflux from cells to the blood. Western blot analysis showed that the protein levels of TRPM6 and CNNM4 were increased by cyanidin, which were blocked by GW6471 (Figure 3A). These results coincided with those from real-time PCR. Immunofluorescence analysis showed that TRPM6 was localized to the apical membrane (Figure 3B). The fluorescence intensity of TRPM6 was enhanced by cyanidin, which was blocked by GW6471. In contrast, CNNM4 was detected in the nuclei and lateral membrane, but the expression was enhanced by cyanidin and was blocked by GW6471.

3.3. Increase in Nuclear Localization of PPARα by Cyanidin

PPARα was mainly localized in the cytosolic compartments in control conditions (Figure 4). Cyanidin increased the nuclear localization of PPARα. The effect of cyanidin was blocked by GW6471, but not by GW9662. These results supported the view that cyanidin may increase TRPM6 and CNNM4 expression mediated by the nuclear trafficking of PPARα.

3.4. Effects of Cyanidin and Inhibitors on TRPM6 and CNNM4 Promoter Activities

To clarify the effect of cyanidin on transcriptional activity, we measured the promoter luciferase activities of Mg2+ transport carriers. Cyanidin increased luciferase activities in cells transfected with wild-type constructs of TRPM6 or CNNM4 (Figure 5). The effects of cyanidin were significantly blocked by GW6471, but not by GW9662. The cyanidin-induced elevation of luciferase activities was also inhibited by the mutation of PPRE in the promoter region of TRPM6 and CNNM4. These results indicated that cyanidin may enhance the transcriptional activities of TRPM6 and CNNM4 mediated by the activation of PPARα.

3.5. Association of PPARα with the TRPM6 and CNNM4 Promoter Regions

In the ChIP assay, a primer pair that amplifies the region containing PPRE of TRPM6 and CNNM4 showed weak PCR signals in vehicle-treated cells (Figure 6). In contrast, PCR signals were detected in cyanidin-treated cells, which were blocked by GW6471. In the input images, similar PCR signals were detected in all samples. These results indicated that cyanidin may enhance the association of PPARα with the TRPM6 and CNNM4 promoter regions.

3.6. Increase in Mg2+ Transport by Cyanidin

To clarify whether TRPM6 and CNNM4 are functionally expressed in MCE301 cells, we examined the effect of cyanidin on Mg2+ transport. In the Mg2+ influx assay, the addition of 1 mM MgCl2 in the extracellular solution increased the fluorescence intensity of KMG-20, a Mg2+-sensitive fluorescent dye (Figure 7A). Cyanidin significantly enhanced the elevation of fluorescence intensity, which was blocked by GW6471. Similar results were observed using cyanidin-3G. Next, we investigated the effect of cyanidin on Mg2+ efflux. The removal of MgCl2 from the extracellular solution induced the decrease in the fluorescence intensity of KMG-20 (Figure 7B). Cyanidin significantly exaggerated the decrease in fluorescence intensity, which was blocked by GW6471. In contrast, GW9662 had no effects on cyanidin and cyanidin-3G-induced Mg2+ influx and efflux. These results indicated that cyanidin may increase the expression of functional TRPM6 and CNNM4. Finally, we examined the effect of cyanidin on transcellular ion permeability. TER was not significantly changed by the treatment with cyanidin, cyanidin-3G, or GW6471 (Figure 8). In contrast, transepithelial Mg2+ flux was enhanced by cyanidin and cyanidin-3G, which was completely inhibited by GW6471. These results indicated that cyanidin and cyanidin-3G can increase colonic Mg2+ transport.

4. Discussion

Dietary Mg2+ is absorbed through transcellular and paracellular pathways in the intestine. The paracellular transport of ions is restricted by claudins, tight junctional transmembrane proteins [26]. In contrast, it was for a long time unknown what carrier proteins are involved with transcellular Mg2+ absorption in the colon. Recently, the involvement of TRPM6 and CNNM4 was identified [9,12]. In the present study, we found that cyanidin and cyanidin-3G increased TRPM6 and CNNM4 expression in colonic MCE301 cells (Figure 1 and Figure 2).
Cyanidin-3G seems to be stable to acid pH and digestive enzymes in the stomach [27]. Approximately 1%–10% of cyanidin-3G is absorbed by the gastric epithelia mediated via transcellular pathways such as sodium-dependent glucose transporter (SGLT1), sodium-independent glucose transporter (GLUT1 and 3), and mono-carboxylated transporter 1. The transport system of cyanidin-3G in the intestine has been well characterized using Caco-2 cells derived from human colonic carcinoma. The absorption of cyanidin-3G is mainly regulated by SGLT1 and GLUT2 [28], but there might be another transport carrier for flavonols, because quercetin-3-glucose seems to inhibit cyanidin-3G absorption [29]. In contrast, cyanidin, the aglycon of cyanidin-3G, is more hydrophobic, thereby allowing diffusion across the plasma membrane. Both cyanidin-3G and cyanidin could increase the mRNA levels of TRPM6 and CNNM4 in MCE301 cells. Therefore, the structure of cyanidin may be necessary for the elevation of these Mg2+ transport carriers.
The cyanidin-induced elevation of TRPM6 and CNNM4 expression was inhibited by GW6471, but not by GW9662 and GSK3787, suggesting the involvement of PPARα. The nuclear trafficking of PPARα by cyanidin was blocked by GW6471, supporting the suggestion that cyanidin activates PPARα. Cyanidin binds directly to PPARα, PPARδ/β, and PPARγ, followed by activating the three PPAR subtypes-specific responsive genes [25]. The affinity for PPARα (KD: 3.08 μM) is higher than those for PPARγ (KD: 24.50 μM) and PPARδ/β (KD: 389.01 μM). Another reason may be explained by the difference in expression levels of PPAR subtypes. The expression level of PPARα is higher than those of PPARβ and PPARγ in the intestine of adult rats [30]. Therefore, the effect of cyanidin on Mg2+ transport carriers may mainly occur through the activation of PPARα.
The transcriptional mechanisms of TRPM6 and CNNM4 genes have not been clarified in detail. Thus far, we reported that EGF, tumor necrosis factor-α, and PPARγ agonists increased the mRNA levels of TRPM6 in renal tubular epithelial cells [22,31,32]. In contrast, there are no reports concerning the transcriptional regulatory factor of CNNM4. This is the first report showing that the transcriptional activities both of TRPM6 and CNNM4 are up-regulated by PPARα in colonic epithelial cells (Figure 5). The cyanidin-induced elevation of luciferase activity disappeared after treatment with GW6471 or mutation in a putative PPRE of the TRPM6 and CNNM4 promoters. Similarly, cyanidin increased the association of PPARα with the promoter region containing the PPRE, which was suppressed by GW6471. We suggest that cyanidin up-regulates the transcriptional activities of TRPM6 and CNNM4 genes mediated by the nuclear trafficking of PPARα and its binding to PPRE of the promoter region.
In the Mg2+ influx and efflux assays, cyanidin-3G and cyanidin significantly enhanced Mg2+ transport, which was blocked by GW6471 (Figure 7). These results suggested that both TRPM6 and CNNM4 are functionally expressed in MCE301 cells. Furthermore, cyanidin-3G and cyanidin increased transepithelial Mg2+ flux without affecting TER (Figure 8). We do not know the reason why TER was changed by cyanidin-3G and cyanidin in spite of the elevation of divalent cation flux. There are possibility that the flux of Mg2+ is negligible small compared to that of other ions, or cyanidin-3G and cyanidin can enhance the flux of anion. Anyway, we suggest that cyanidin-3G and cyanidin did not disrupt the paracellular barrier, but they can enhance Mg2+ absorption mediated through the transcellular pathway. The cell surface expression in the apical membrane of TRPM6 is regulated by Rac1, a small Rho GTPase [33]. On the other hand, the basolateral sorting of CNNM4 requires interactions with AP-1A and AP-1B [34]. Immunofluorescence analysis indicated that the green signal of TRPM6 is detected in the apical side (Figure 3B). In contrast, the red signal of CNNM4 was detected not only in the lateral membrane, but also in the nuclei. It may be useful to search for compounds that can enhance the trafficking of CNNM4 to the basolateral membrane.

5. Conclusions

In the present study, we found that cyanidin-3G and cyanidin increase TRPM6 and CNNM4 expression in MCE301 cells. Cyanidin-induced nuclear trafficking and association of PPARα with the promoter regions of TRPM6 and CNNM4 were significantly inhibited by GW6471. In addition, cyanidin increased reporter activity of TRPM6 and CNNM4, which was inhibited by mutation in PPRE sequences. Cyanidin-3G and cyanidin might increase TRPM6-mediated Mg2+ influx and CNNM4-mediated Mg2+ efflux, resulting in the elevation of transepithelial Mg2+ absorption in the colon. The presumed action mechanism of cyanidine-3G and cyanidin is illustrated in Figure 9. Foods abundant in cyanidin-3G might be sources of these phytochemicals that can improve Mg2+ deficiency.

Author Contributions

Y.T. and A.M. performed experiments and analyzed the data. Y.T. contributed to the discussion. A.I. contributed to supervision of the project, interpretation of the data, and writing the paper.

Acknowledgments

This work was supported in part by JSPS KAKENHI Grant Number 15H04657 (A.I.), and the grants from the Fuji Foundation for Protein Research, Salt Science Research Foundation (1627), and Kurata Grant awarded by the Hitachi Global Foundation (1341).

Conflicts of Interest

The authors declare that they have no conflicts of interest with the contents of this article.

Abbreviations

ChIPChromatin immunoprecipitation
CNNM4Cyclin M4
CtThreshold cycle
Cyanidin-3GCyanidin-3-O-glucoside
DAPI4′,6-Diamidino-2-phenylindole
DMSODimethyl sulfoxide
EGFEpidermal growth factor
GLUTSodium-independent glucose transporter
HBSSHank’s balanced salt solution
Mg2+Magnesium ion
[Mg2+]i,Intracellular free Mg2+ concentration
PCRPolymerase chain reaction
PKAProtein kinase A
PPARPeroxisome proliferator-activated receptor
SGLTSodium-dependent glucose transporter
TERTransepithelial electrical resistance
TRPM6Transient receptor potential melastatin 6
XB-1Xylidyl blue-I

References

  1. Takayanagi, K.; Shimizu, T.; Tayama, Y.; Ikari, A.; Anzai, N.; Iwashita, T.; Asakura, J.; Hayashi, K.; Mitarai, T.; Hasegawa, H. Downregulation of transient receptor potential M6 channels as a cause of hypermagnesiuric hypomagnesemia in obese type 2 diabetic rats. Am. J. Physiol. Ren. Physiol. 2015, 308, F1386–F1397. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. De Leeuw, I.H.; van Gaal, L.; Vanroelen, W. Magnesium and obesity: Effects of treatment on magnesium and other parameters. Magnesium 1987, 6, 40–47. [Google Scholar]
  3. Dousdampanis, P.; Trigka, K.; Fourtounas, C. Hypomagnesemia, chronic kidney disease and cardiovascular mortality: Pronounced association but unproven causation. Hemodial. Int. 2014, 18, 730–739. [Google Scholar] [CrossRef] [PubMed]
  4. Zieba, A.; Kata, R.; Dudek, D.; Schlegel-Zawadzka, M.; Nowak, G. Serum trace elements in animal models and human depression: Part III. Magnesium. Relationship with copper. Hum. Psychopharmacol. 2000, 15, 631–635. [Google Scholar] [PubMed]
  5. Golf, S.W.; Bender, S.; Gruttner, J. On the significance of magnesium in extreme physical stress. Cardiovasc. Drugs Ther. 1998, 12 (Suppl. 2), 197–202. [Google Scholar] [CrossRef] [PubMed]
  6. Schweigel, M.; Martens, H. Magnesium transport in the gastrointestinal tract. Front. Biosci. 2000, 5, D666–D677. [Google Scholar] [CrossRef]
  7. Graham, L.A.; Caesar, J.J.; Burgen, A.S. Gastrointestinal absorption and excretion of Mg 28 in man. Metabolism 1960, 9, 646–659. [Google Scholar]
  8. De Baaij, J.H.; Hoenderop, J.G.; Bindels, R.J. Magnesium in man: Implications for health and disease. Physiol. Rev. 2015, 95, 1–46. [Google Scholar] [CrossRef]
  9. Voets, T.; Nilius, B.; Hoefs, S.; van der Kemp, A.W.; Droogmans, G.; Bindels, R.J.; Hoenderop, J.G. TRPM6 forms the Mg2+ influx channel involved in intestinal and renal Mg2+ absorption. J. Biol. Chem. 2004, 279, 19–25. [Google Scholar] [CrossRef] [PubMed]
  10. Schlingmann, K.P.; Weber, S.; Peters, M.; Niemann Nejsum, L.; Vitzthum, H.; Klingel, K.; Kratz, M.; Haddad, E.; Ristoff, E.; Dinour, D.; et al. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat. Genet. 2002, 31, 166–170. [Google Scholar] [CrossRef] [PubMed]
  11. Walder, R.Y.; Landau, D.; Meyer, P.; Shalev, H.; Tsolia, M.; Borochowitz, Z.; Boettger, M.B.; Beck, G.E.; Englehardt, R.K.; Carmi, R.; et al. Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nat. Genet. 2002, 31, 171–174. [Google Scholar] [CrossRef]
  12. Yamazaki, D.; Funato, Y.; Miura, J.; Sato, S.; Toyosawa, S.; Furutani, K.; Kurachi, Y.; Omori, Y.; Furukawa, T.; Tsuda, T.; et al. Basolateral Mg2+ extrusion via CNNM4 mediates transcellular Mg2+ transport across epithelia: A mouse model. PLoS Genet. 2013, 9, e1003983. [Google Scholar] [CrossRef]
  13. Meyer, T.E.; Verwoert, G.C.; Hwang, S.J.; Glazer, N.L.; Smith, A.V.; van Rooij, F.J.; Ehret, G.B.; Boerwinkle, E.; Felix, J.F.; Leak, T.S.; et al. Genome-wide association studies of serum magnesium, potassium, and sodium concentrations identify six Loci influencing serum magnesium levels. PLoS Genet. 2010, 6, e1001045. [Google Scholar] [CrossRef]
  14. Schuchardt, J.P.; Hahn, A. Intestinal Absorption and Factors Influencing Bioavailability of Magnesium-An Update. Curr. Nutr. Food Sci. 2017, 13, 260–278. [Google Scholar] [CrossRef]
  15. Hoenderop, J.G.; Bindels, R.J. Calciotropic and magnesiotropic TRP channels. Physiology 2008, 23, 32–40. [Google Scholar] [CrossRef]
  16. Elin, R.J. Magnesium metabolism in health and disease. Dis. Mon. 1988, 34, 161–218. [Google Scholar] [CrossRef]
  17. Hanai, M.; Esashi, T. Bioavailability of magnesium contained in roasted and ground soybean (kinako) as evaluated by serum and bone magnesium contents, kidney calcification, and magnesium absorption. J. Nutr. Sci. Vitaminol. 1998, 44, 437–446. [Google Scholar] [CrossRef] [PubMed]
  18. Tsuda, T.; Horio, F.; Osawa, T. Absorption and metabolism of cyanidin 3-O-beta-d-glucoside in rats. FEBS Lett. 1999, 449, 179–182. [Google Scholar] [CrossRef]
  19. Olivas-Aguirre, F.J.; Rodrigo-Garcia, J.; Martinez-Ruiz, N.D.; Cardenas-Robles, A.I.; Mendoza-Diaz, S.O.; Alvarez-Parrilla, E.; Gonzalez-Aguilar, G.A.; de la Rosa, L.A.; Ramos-Jimenez, A.; Wall-Medrano, A. Cyanidin-3-O-glucoside: Physical-Chemistry, Foodomics and Health Effects. Molecules 2016, 21, 1264. [Google Scholar] [CrossRef]
  20. Tabuchi, Y.; Ohta, S.; Arai, Y.; Kawahara, M.; Ishibashi, K.; Sugiyama, N.; Horiuchi, T.; Furusawa, M.; Obinata, M.; Fuse, H.; et al. Establishment and characterization of a colonic epithelial cell line MCE301 from transgenic mice harboring temperature-sensitive simian virus 40 large T-antigen gene. Cell Struct. Funct. 2000, 25, 297–307. [Google Scholar] [CrossRef]
  21. Furukawa, C.; Ishizuka, N.; Hayashi, H.; Fujii, N.; Manabe, A.; Tabuchi, Y.; Matsunaga, T.; Endo, S.; Ikari, A. Up-regulation of claudin-2 expression by aldosterone in colonic epithelial cells of mice fed with NaCl-depleted diets. Sci. Rep. 2017, 7, 12223. [Google Scholar] [CrossRef] [Green Version]
  22. Furukawa, C.; Fujii, N.; Manabe, A.; Matsunaga, T.; Endo, S.; Hasegawa, H.; Ito, Y.; Yamaguchi, M.; Yamazaki, Y.; Ikari, A. Up-regulation of transient receptor potential melastatin 6 channel expression by tumor necrosis factor-alpha in the presence of epidermal growth factor receptor tyrosine kinase inhibitor. J. Cell. Physiol. 2017, 232, 2841–2850. [Google Scholar] [CrossRef]
  23. Manabe, A.; Furukawa, C.; Endo, S.; Marunaka, K.; Nishiyama, T.; Fujii, N.; Tabuchi, Y.; Matsunaga, T.; Ikari, A. Chlorpheniramine Increases Paracellular Permeability to Marker Fluorescein Lucifer Yellow Mediated by Internalization of Occludin in Murine Colonic Epithelial Cells. Biol. Pharm. Bull. 2017, 40, 1299–1305. [Google Scholar] [CrossRef] [Green Version]
  24. Zhu, W.; Jia, Q.; Wang, Y.; Zhang, Y.; Xia, M. The anthocyanin cyanidin-3-O-beta-glucoside, a flavonoid, increases hepatic glutathione synthesis and protects hepatocytes against reactive oxygen species during hyperglycemia: Involvement of a cAMP-PKA-dependent signaling pathway. Free Radic. Biol. Med. 2012, 52, 314–327. [Google Scholar] [CrossRef]
  25. Jia, Y.; Kim, J.Y.; Jun, H.J.; Kim, S.J.; Lee, J.H.; Hoang, M.H.; Kim, H.S.; Chang, H.I.; Hwang, K.Y.; Um, S.J.; et al. Cyanidin is an agonistic ligand for peroxisome proliferator-activated receptor-alpha reducing hepatic lipid. Biochim. Biophys. Acta 2013, 1831, 698–708. [Google Scholar] [CrossRef]
  26. Lu, Z.; Ding, L.; Lu, Q.; Chen, Y.H. Claudins in intestines: Distribution and functional significance in health and diseases. Tissue Barriers 2013, 1, e24978. [Google Scholar] [CrossRef]
  27. Kopf-Bolanz, K.A.; Schwander, F.; Gijs, M.; Vergeres, G.; Portmann, R.; Egger, L. Validation of an in vitro digestive system for studying macronutrient decomposition in humans. J. Nutr. 2012, 142, 245–250. [Google Scholar] [CrossRef]
  28. Zou, T.B.; Feng, D.; Song, G.; Li, H.W.; Tang, H.W.; Ling, W.H. The role of sodium-dependent glucose transporter 1 and glucose transporter 2 in the absorption of cyanidin-3-o-beta-glucoside in Caco-2 cells. Nutrients 2014, 6, 4165–4177. [Google Scholar] [CrossRef]
  29. Walton, M.C.; McGhie, T.K.; Reynolds, G.W.; Hendriks, W.H. The flavonol quercetin-3-glucoside inhibits cyanidin-3-glucoside absorption in vitro. J. Agric. Food Chem. 2006, 54, 4913–4920. [Google Scholar] [CrossRef]
  30. Braissant, O.; Foufelle, F.; Scotto, C.; Dauca, M.; Wahli, W. Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 1996, 137, 354–366. [Google Scholar] [CrossRef]
  31. Ikari, A.; Sanada, A.; Okude, C.; Sawada, H.; Yamazaki, Y.; Sugatani, J.; Miwa, M. Up-regulation of TRPM6 transcriptional activity by AP-1 in renal epithelial cells. J. Cell. Physiol. 2010, 222, 481–487. [Google Scholar] [CrossRef]
  32. Manabe, A.; Furukawa, C.; Hasegawa, H.; Matsunaga, T.; Endo, S.; Ikari, A. Upregulation of transient receptor potential melastatin 6 channel expression by rosiglitazone and all-trans-retinoic acid in erlotinib-treated renal tubular epithelial cells. J. Cell. Physiol. 2018. [Google Scholar] [CrossRef]
  33. Thebault, S.; Alexander, R.T.; Tiel Groenestege, W.M.; Hoenderop, J.G.; Bindels, R.J. EGF increases TRPM6 activity and surface expression. J. Am. Soc. Nephrol. 2009, 20, 78–85. [Google Scholar] [CrossRef]
  34. Hirata, Y.; Funato, Y.; Miki, H. Basolateral sorting of the Mg2+ transporter CNNM4 requires interaction with AP-1A and AP-1B. Biochem. Biophys. Res. Commun. 2014, 455, 184–189. [Google Scholar] [CrossRef]
Figure 1. Increase in TRPM6 and CNNM4 expression levels by cyanidin treatment. MCE301 cells were incubated with vehicle (DMSO), 10 μM genistein, 10 μM cyanidin, or 10 μM linoleic acid for 6 h. After isolation of total RNA, quantitative real-time PCR was performed using primer pairs for TRPM6, TRPM7, CNNM4, and β-actin. The contents of TRPM6 (A), TRPM7 (B), and CNNM4 mRNAs (C) were represented relative to the values in vehicle. n = 4. ** p < 0.01 and NS p > 0.05 compared with vehicle.
Figure 1. Increase in TRPM6 and CNNM4 expression levels by cyanidin treatment. MCE301 cells were incubated with vehicle (DMSO), 10 μM genistein, 10 μM cyanidin, or 10 μM linoleic acid for 6 h. After isolation of total RNA, quantitative real-time PCR was performed using primer pairs for TRPM6, TRPM7, CNNM4, and β-actin. The contents of TRPM6 (A), TRPM7 (B), and CNNM4 mRNAs (C) were represented relative to the values in vehicle. n = 4. ** p < 0.01 and NS p > 0.05 compared with vehicle.
Nutrients 11 00641 g001
Figure 2. Inhibition of cyanidin-induced TRPM6 and CNNM4 expression by GW6471. (A) MCE301 cells were incubated with vehicle, 10 μM GW9662, 10 μM GW6471, 10 μM GSK3787, or 10 μM H-89 in the presence and absence of 10 μM cyanidin for 6 h. Quantitative real-time PCR was performed using primer pairs for TRPM6, CNNM4, and β-actin. The contents of TRPM6 and CNNM4 mRNAs are represented relative to the values in vehicle. (B) MCE301 cells were incubated with vehicle, 10 μM GW9662 or 10 μM H-89 in the presence and absence of 10 μM cyanidin-3G for 6 h. Quantitative real-time PCR was performed using primer pairs for TRPM6, CNNM4, and β-actin. The contents of TRPM6 and CNNM4 mRNAs are represented relative to the values in vehicle. n = 4. ** p < 0.01 and NS p > 0.05 compared with vehicle. ## p < 0.01 and # p < 0.05 compared without cyanidin or cyanidin-3G alone.
Figure 2. Inhibition of cyanidin-induced TRPM6 and CNNM4 expression by GW6471. (A) MCE301 cells were incubated with vehicle, 10 μM GW9662, 10 μM GW6471, 10 μM GSK3787, or 10 μM H-89 in the presence and absence of 10 μM cyanidin for 6 h. Quantitative real-time PCR was performed using primer pairs for TRPM6, CNNM4, and β-actin. The contents of TRPM6 and CNNM4 mRNAs are represented relative to the values in vehicle. (B) MCE301 cells were incubated with vehicle, 10 μM GW9662 or 10 μM H-89 in the presence and absence of 10 μM cyanidin-3G for 6 h. Quantitative real-time PCR was performed using primer pairs for TRPM6, CNNM4, and β-actin. The contents of TRPM6 and CNNM4 mRNAs are represented relative to the values in vehicle. n = 4. ** p < 0.01 and NS p > 0.05 compared with vehicle. ## p < 0.01 and # p < 0.05 compared without cyanidin or cyanidin-3G alone.
Nutrients 11 00641 g002
Figure 3. Increase in the expression levels of TRPM6 and CNNM4 protein by cyanidin treatment. (A) MCE301 cells were incubated with vehicle or 10 μM GW6471 in the presence and absence of 10 μM cyanidin for 24 h. Cytoplasmic extracts were immunoblotted with anti-TRPM6 or anti-CNNM4 antibodies. The expression levels were represented relative to the values with the absence of cyanidin. (B) MCE301 cells cultured on Transwell inserts were stained with anti-TRPM6 (green) and anti-CNNM4 (red) antibodies in the presence of DAPI (blue). The upper and right images represent the xz section. Scale bar indicates 20 μm. n = 4. ** p < 0.01 and * p < 0.05 compared without cyanidin. # p < 0.05 compared with cyanidin alone.
Figure 3. Increase in the expression levels of TRPM6 and CNNM4 protein by cyanidin treatment. (A) MCE301 cells were incubated with vehicle or 10 μM GW6471 in the presence and absence of 10 μM cyanidin for 24 h. Cytoplasmic extracts were immunoblotted with anti-TRPM6 or anti-CNNM4 antibodies. The expression levels were represented relative to the values with the absence of cyanidin. (B) MCE301 cells cultured on Transwell inserts were stained with anti-TRPM6 (green) and anti-CNNM4 (red) antibodies in the presence of DAPI (blue). The upper and right images represent the xz section. Scale bar indicates 20 μm. n = 4. ** p < 0.01 and * p < 0.05 compared without cyanidin. # p < 0.05 compared with cyanidin alone.
Nutrients 11 00641 g003
Figure 4. Increase in nuclear localization of PPARα by cyanidin. (A) MCE301 cells were incubated with vehicle, 10 μM GW6471, or 10 μM GW9662 in the presence and absence of 10 μM cyanidin for 1 h. The cells were stained with anti-PPARα antibody (red) and DAPI (blue). Merged images are shown in the right. Scale bar indicates 20 μm. (B) The fluorescence intensities of PPARα in the nuclei were measured using Image J and represented relative to the values of total fluorescence intensities. n = 4. ** p < 0.01 compared without cyanidin. ## p < 0.01 and NS p > 0.05 compared with cyanidin alone.
Figure 4. Increase in nuclear localization of PPARα by cyanidin. (A) MCE301 cells were incubated with vehicle, 10 μM GW6471, or 10 μM GW9662 in the presence and absence of 10 μM cyanidin for 1 h. The cells were stained with anti-PPARα antibody (red) and DAPI (blue). Merged images are shown in the right. Scale bar indicates 20 μm. (B) The fluorescence intensities of PPARα in the nuclei were measured using Image J and represented relative to the values of total fluorescence intensities. n = 4. ** p < 0.01 compared without cyanidin. ## p < 0.01 and NS p > 0.05 compared with cyanidin alone.
Nutrients 11 00641 g004
Figure 5. Involvement of PPARα on the cyanidin-induced elevation of TRPM6 and CNNM4 promoter activities. TRPM6 promoter (A) or CNNM4 promoter (B) luciferase vectors were co-transfected with a pRL-TK vector into MCE301 cells. WT and mutant indicate vectors with wild-type and mutant PPRE sequences, respectively. At 24 h after transfection, the cells were incubated with vehicle, 10 μM cyanidin, cyanidin plus 10 μM GW6471, or cyanidin plus 10 μM GW9662 for 6 h. The relative promoter activity was represented relative to the values in vehicle. n = 3–4. ** p < 0.01 and NS p > 0.05 compared with vehicle. ## p < 0.01 compared without cyanidin alone.
Figure 5. Involvement of PPARα on the cyanidin-induced elevation of TRPM6 and CNNM4 promoter activities. TRPM6 promoter (A) or CNNM4 promoter (B) luciferase vectors were co-transfected with a pRL-TK vector into MCE301 cells. WT and mutant indicate vectors with wild-type and mutant PPRE sequences, respectively. At 24 h after transfection, the cells were incubated with vehicle, 10 μM cyanidin, cyanidin plus 10 μM GW6471, or cyanidin plus 10 μM GW9662 for 6 h. The relative promoter activity was represented relative to the values in vehicle. n = 3–4. ** p < 0.01 and NS p > 0.05 compared with vehicle. ## p < 0.01 compared without cyanidin alone.
Nutrients 11 00641 g005
Figure 6. Association of PPARα with PPRE in the TRPM6 and CNNM4 promoters. MCE301 cells were incubated with vehicle or 10 μM GW6471 in the absence and presence of 10 μM cyanidin for 2 h. Genomic DNA was immunoprecipitated with an anti-PPARα antibody. After immunoprecipitation, the 5′-flanking region of TNRP6 was amplified by semi-quantitative (A) and quantitative PCR (B) using primer pairs amplifying PPRE from TRPM6 and CNNM4. Input was amplified by the primer without immunoprecipitation. ChIP data are represented relative to the values in cyanidin alone. n = 3.
Figure 6. Association of PPARα with PPRE in the TRPM6 and CNNM4 promoters. MCE301 cells were incubated with vehicle or 10 μM GW6471 in the absence and presence of 10 μM cyanidin for 2 h. Genomic DNA was immunoprecipitated with an anti-PPARα antibody. After immunoprecipitation, the 5′-flanking region of TNRP6 was amplified by semi-quantitative (A) and quantitative PCR (B) using primer pairs amplifying PPRE from TRPM6 and CNNM4. Input was amplified by the primer without immunoprecipitation. ChIP data are represented relative to the values in cyanidin alone. n = 3.
Nutrients 11 00641 g006
Figure 7. Elevation of Mg2+ influx and efflux from cells by cyanidin. (A) MCE301 cells were incubated with vehicle, 10 μM GW6471, or 10 μM GW9662 in the presence of 10 μM cyanidin or 10 μM cyanidin-3G for 24 h. MgCl2 (1 mM) was added to the nominally Mg2+-free HBSS immediately after the start of the measurements. The increase in fluorescence values for 5 min was compared in each group. (B) The HBSS containing 1 mM MgCl2 was replaced to the nominally Mg2+-free HBSS immediately after the start of the measurements. The decrease in fluorescence values for 5 min was compared in each group. n = 4–6. ** p < 0.01 and * p < 0.05 compared without cyanidin. ## p < 0.01 and NS p > 0.05 compared with vehicle.
Figure 7. Elevation of Mg2+ influx and efflux from cells by cyanidin. (A) MCE301 cells were incubated with vehicle, 10 μM GW6471, or 10 μM GW9662 in the presence of 10 μM cyanidin or 10 μM cyanidin-3G for 24 h. MgCl2 (1 mM) was added to the nominally Mg2+-free HBSS immediately after the start of the measurements. The increase in fluorescence values for 5 min was compared in each group. (B) The HBSS containing 1 mM MgCl2 was replaced to the nominally Mg2+-free HBSS immediately after the start of the measurements. The decrease in fluorescence values for 5 min was compared in each group. n = 4–6. ** p < 0.01 and * p < 0.05 compared without cyanidin. ## p < 0.01 and NS p > 0.05 compared with vehicle.
Nutrients 11 00641 g007
Figure 8. Elevation of transepithelial Mg2+ transport by cyanidin. MCE301 cells cultured on Transwell inserts were incubated with vehicle or 10 μM GW6471 in the presence of 10 μM cyanidin or 10 μM cyanidin-3G for 24 h. (A) TER was measured using volt ohmmeter. (B) The upper and lower chamber solutions were replaced with nominally Mg2+-free HBSS. After 1 mM MgCl2 was added to the upper chamber solution and incubated for 60 min, the lower chamber solution was collected. The concentration of Mg2+ in the lower chamber solution was measured using XB-1 and represented as Mg2+ flux. ** p < 0.01.
Figure 8. Elevation of transepithelial Mg2+ transport by cyanidin. MCE301 cells cultured on Transwell inserts were incubated with vehicle or 10 μM GW6471 in the presence of 10 μM cyanidin or 10 μM cyanidin-3G for 24 h. (A) TER was measured using volt ohmmeter. (B) The upper and lower chamber solutions were replaced with nominally Mg2+-free HBSS. After 1 mM MgCl2 was added to the upper chamber solution and incubated for 60 min, the lower chamber solution was collected. The concentration of Mg2+ in the lower chamber solution was measured using XB-1 and represented as Mg2+ flux. ** p < 0.01.
Nutrients 11 00641 g008
Figure 9. The presumed action mechanism of cyanidine-3G and cyanidin in intestinal epithelial cells.
Figure 9. The presumed action mechanism of cyanidine-3G and cyanidin in intestinal epithelial cells.
Nutrients 11 00641 g009
Table 1. Pharmacological effects of drugs.
Table 1. Pharmacological effects of drugs.
DrugsMode of Action
GW9662PPARγ antagonist
GSK3787PPARδ antagonist
GW6471PPARα antagonist
H-89PKA inhibitor
Table 2. Primer list for real time PCR.
Table 2. Primer list for real time PCR.
TRPM6Sense5′-ACCACCTAAGGCAGATGCAA-3′
Antisense5′-CAACTTCATTTGGGCTTCTTG-3′
TRPM7Sense5′-AACCAACACTCTGGAAGAGATCA-3′
Antisense5′-TCAGTCAAGTTTTCTCCCACAC-3′
CNNM4Sense5′-TGATGGAGATGTTGAAGGTGAC-3′
Antisense5′-CCTCCACAGTTTTGGTCCTTAG-3′
β-ActinSense5′-CCAACCGTGAAAAGATGACC-3′
Antisense5′-CCAGAGGCATACAGGGACAG-3′
Table 3. Primer list for the introduction of mutations.
Table 3. Primer list for the introduction of mutations.
TRPM6Sense5′-GACTGAAGGATGCAGTGAGCCATGATCCTGC-3′
Antisense5′-CCCAGGCTCAAGTGATCCTTCCACT-3′
CNNM4Sense5′-GAATTCTTGCCCCAATTCTCTGGTTAGCAAG-3′
Antisense5′-TTACCTCTTACGGCCTTGGTTTCTC-3′
Table 4. Primer list for ChIP assays.
Table 4. Primer list for ChIP assays.
TRPM6Sense5′-CCAGGTTTTATGGCTACTGGAC-3′
Antisense5′-GACGTATGACTACGGGCTTCTC-3′
CNNM4Sense5′-CTGCCATTTTTCTGATGATAGG-3′
Antisense5′-TCTGACCTAGGTTTTTCACCTG-3′

Share and Cite

MDPI and ACS Style

Takashina, Y.; Manabe, A.; Tabuchi, Y.; Ikari, A. Cyanidin Increases the Expression of Mg2+ Transport Carriers Mediated by the Activation of PPARα in Colonic Epithelial MCE301 Cells. Nutrients 2019, 11, 641. https://doi.org/10.3390/nu11030641

AMA Style

Takashina Y, Manabe A, Tabuchi Y, Ikari A. Cyanidin Increases the Expression of Mg2+ Transport Carriers Mediated by the Activation of PPARα in Colonic Epithelial MCE301 Cells. Nutrients. 2019; 11(3):641. https://doi.org/10.3390/nu11030641

Chicago/Turabian Style

Takashina, Yui, Aya Manabe, Yoshiaki Tabuchi, and Akira Ikari. 2019. "Cyanidin Increases the Expression of Mg2+ Transport Carriers Mediated by the Activation of PPARα in Colonic Epithelial MCE301 Cells" Nutrients 11, no. 3: 641. https://doi.org/10.3390/nu11030641

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop